Sign In  |  Register  |  About Mill Valley  |  Contact Us

Mill Valley, CA
September 01, 2020 1:29pm
7-Day Forecast | Traffic

  • Search Hotels in Mill Valley

  • CHECK-IN:
  • CHECK-OUT:
  • ROOMS:
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY: JNJ )

155.01 -0.39 (-0.25%)
Official Closing Price Updated: 5:00 PM EST, Nov 29, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
99 100 Next >
5 Phenomenal Stocks in Warren Buffett's "Secret" Portfolio That Are Screaming Buys in 2024
The Oracle of Omaha's $610 million hidden portfolio has five amazing bargains hiding in plain sight. 
Via The Motley Fool
Benzinga's 'Stock Whisper' Index: 5 Stocks Investors Secretly Monitor But Don't Talk About Yet
A weekly look at top trending tickers seeing increased attention from Benzinga users. 
Via Benzinga
7 Tech Stocks to Light Up Your Portfolio This Holiday Season
Are you looking for the best tech stocks this holiday season? Here are seven stocks to light up your portfolio this holiday season. 
Via InvestorPlace
Johnson & Johnson to Participate in the 42nd Annual J.P. Morgan Healthcare Conference
From Johnson & Johnson
Via Business Wire
(JNJ) - Analyzing Johnson & Johnson's Short Interest
Via Benzinga
Investing in the Aging Population: 3 Healthcare Stocks to Watch
America is becoming a much older country on average. These three healthcare stocks are ideally positioned for this demographic shift. 
Via InvestorPlace
Vanda Pharmaceuticals Acquires Rights To Multiple Sclerosis Drug From Johnson & Johnson's Company
Vanda Pharmaceuticals Inc (NASDAQ: VNDA) has acquired U.S. 
Via Benzinga
JNJ CEO Signals No Rush Into Weight-Loss Drug Realm, Emphasizes Different Priorities
Johnson & Johnson (NYSE: JNJ) has no immediate plans to venture into weight-loss drugs due to the existing competition saturation, as Chief Executive Officer  
Via Benzinga
Elliott Wave Technical Analysis: Johnson & Johnson
Looking for longs into wave (v). 
Via Talk Markets
Bargain Buys: 7 Stocks Lagging the S&P 500 With Big Potential
While it might be tempting to jump onboard the top winners in the S&P 500, these bargain stocks might offer superior upside. 
Via InvestorPlace
Topics Stocks
Exposures US Equities
Financial Resources Federal Credit Union Goes Live With Scienaptic's AI Platform
Increased automation will continue to support Credit Union's Growth and MissionNEW YORK - Dec. 6, 2023 - PRLog -- Leading global AI-powered credit decision platform provider, Scienaptic AI, announced... 
Via PRLog
Topics Artificial Intelligence
Exposures Artificial Intelligence
Johnson & Johnson Settles Multiple Lawsuits Over Talc Cancer Claims, Eyes Prepackaged Bankruptcy
Johnson & Johnson's (NYSE: JNJ) worldwide vice president for litigation, Erik Haas, disclosed recent settlements with several law firms regarding claims linking J&J talc  
Via Benzinga
Topics Lawsuit
Exposures Financial Legal
Is Buffett Turning Bearish? 7 Stocks Warren Completely Dumped in Q3
Warren Buffett stocks are typically bought to be held for a long time but sometimes even he finds it necessary to sell. 
Via InvestorPlace
Johnson & Johnson's Strategic Forecast: Targets 5%-6% Operational Sales Growth For FY24
Johnson & Johnson (NYSE: JNJ) expects operational sales growth in the  
Via Benzinga
Unleashing Growth Potential: Johnson &amp; Johnson Surpasses Expectations with Strong Performance and Increasing Profits
Via Benzinga
Nasdaq 100 Forecast: Stocks Slip For A Second Day With Jobs Data In Focus
Stocks are heading for a second day of losses as investors look ahead to data releases ahead of Friday's key non-farm payroll and next week's FOMC meeting. 
Via Talk Markets
Johnson & Johnson Announces Key Drivers for Long-Term Competitive Growth at Enterprise Business Review
From Johnson & Johnson
Via Business Wire
The 7 Best Ways to Invest $1,000 in the Stock Market Now
Take a look at the seven best ways to invest $1,000 in the stock market and build a portfolio that generates passive income and gains. 
Via InvestorPlace
Top Contenders Emerge in Johnson & Johnson's Race for New CEO, Plans Under Spotlight After Unexpected Departure
The race for Johnson & Johnson's (NYSE: JNJ) top executive position has intensified following the unexpected exit of Ashley McEvoy, the former head of the company's medical device unit, potentially... 
Via Benzinga
Supreme Court Decision Looms Over Purdue Pharma's $6B Opioid Settlement And Sackler Family Immunity
The fate of a $6 billion bankruptcy settlement involving Purdue Pharma, the maker of the powerful and addictive pain medication OxyContin, hangs in th 
Via Benzinga
Topics Bankruptcy
Exposures Financial Legal
Doing Your Holiday Shopping? These Stocks Might Make Great Gifts
No matter which holiday you're planning gifts for, Christmas, Hanukkah, or some other occasion, there may be one great gift idea you haven't thought of yet. 
Via MarketBeat
Topics Bonds
Exposures Debt Markets
Warren Buffett Just Closed His Position in This Dividend Giant. Should You?
J&J has a long track record of dividend growth -- something Buffett generally appreciates. 
Via The Motley Fool
Barron's Weekend Stock Picks: Uber Joins The S&P 500, Schwab Rebounds And What's Next for Johnson & Johnson?
Benzinga reviews this weekend's top stories covered by Barron's. Here are the articles investors need to read. 
Via Benzinga
Topics Stocks
Exposures US Equities
Johnson & Johnson Gets Analyst Upgrade Noting Bullish Pharma & MedTech Projections
UBS has upgraded Johnson & Johnson (NYSE: JNJ), citing a bullish view of the company's pharmaceutical business and expectations for MedTech growth that align with the market, which is... 
Via Benzinga
Texas Attorney General Alleges Pfizer Misled Public on COVID-19 Vaccine Efficacy
Texas Attorney General Ken Paxton has filed a lawsuit against Pfizer Inc (NYSE: PFE), alleging the pharmaceutical giant misrepresented the efficacy of its widely- 
Via Benzinga
Topics Lawsuit
Exposures COVID-19 Financial Legal
Investors Should Not Pay More Than A 15 P/E Ratio When Buying A Stock
A look at how the P/E ratio can help determine if a stock is trading at a fair valuation or not, and whether it is a good investment. 
Via Talk Markets
Wealth From Wellness: 7 Healthcare Stocks to Inoculate Your Portfolio
Faced with a possible negative outcome in the market, these top healthcare stocks should offer the confidence you need. 
Via InvestorPlace
Warren Buffett Reduced This Long-Time Berkshire Hathaway Holding by 67%. Should Investors Follow His Lead?
Berkshire Hathaway trimmed several longtime holdings in the third quarter, including this stock it has held since 2001. 
Via The Motley Fool
Texas Sues Pfizer For "Misrepresenting COVID-19 Vaccine Efficacy" And "Conspiring To Censor Public Discourse"
The Texas attorney general is suing pharmaceutical giant Pfizer for misrepresenting the effectiveness of the company's Covid-19 
Via Talk Markets
Topics Lawsuit
Exposures COVID-19 Financial Legal
Johnson & Johnson Names Eugene A. Woods, Chief Executive Officer of Advocate Health, to its Board of Directors
From Johnson & Johnson
Via Business Wire
< Previous 1 2
...
26 27 28 29 30 31 32 33 34
...
99 100 Next >
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
 
 
About Us | Contact Us | Privacy Policy | User Agreement | Advertise With Us | Site Map
Copyright © 2010-2020 MillValley.com & California Media Partners, LLC. All rights reserved.